Bethesda, Md. – The Parenteral Drug Association (PDA) announced FujiFilm Kyowa Kirin Biologics, Co., Ltd. has won PDA’s new Drug Delivery Innovation Award and Congruence Medical Solutions and Santen Pharmaceuticals have won PDA’s Partnership in Drug Delivery Innovation Award. The Drug Delivery Awards were introduced in 2019 to recognize technical innovation advancing the field of bio/pharmaceutical manufacturing. The awards were announced at the 2019 Universe of Pre-Filled Syringes and Injection Devices Conference in Gothenburg, Sweden last week.
FujiFilm Kyowa Kirin Biologics Co., Ltd. was selected for the Drug Delivery Innovation Award for its Hulio™ non-citrate polymer syringe. Hulio™ is the biosimilar version of adalimumab. It is a new citrate-free formulation in an innovative container (SOF polymer syringe) with a thinner needle to reduce injection pain. The needle cover is not made of natural rubber latex to avoid latex allergy. This innovative product also has higher breakage resistance and is lighter than glass syringes.
Congruence Medical Solutions and Santen Pharmaceuticals received the Partnership in Drug Delivery Innovation Award for their work on a microliter dosing syringe (MDS). This MDS was conceived to provide an accurate, precise, microliter dose by incorporating a standard pre-fillable syringe. The innovation of this product is extending the range of currently available standard pre-fillable syringes to delivery of microliter doses. Applications can include delivery of proteins, antibodies, viruses, cells, gene, immunotherapeutics in ophthalmology, oncology, neurology, dermatology, and organ delivery, among others.
PDA will present these awards annually at the Universe of Pre-Filled Syringes and Injection Devices Conference. The 2020 event will be held Oct. 5-6 in Las Vegas. To learn more, visit pda.org/2020UPS.